Looking to publish in Transplantation And Cellular Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowTransplantation and Cellular Therapy is the official publication of the American Society for Transplantation and Cellular Therapy and focuses on the interdisciplinary field of hematopoietic cell transplantation and cellular therapies. The journal emphasizes clinical care, treatment outcomes, standards, best practices, evidence-based approaches, current technology, groundbreaking research, and clinical applications. It publishes original research reports, practice guidelines, reviews, editorials, commentaries, and letters to the editor.
Looking to publish in Transplantation And Cellular Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Transplantation And Cellular Therapy accepts the following article types. Click on an article type to view submission instructions.
Regular Manuscripts
Review Articles
Clinical Reviews
Research Communications
Letters
Recent Publications
Valganciclovir for CMV Prophylaxis After PTCy-Based Allogeneic Hematopoietic Cell Transplantation
Nermen Tawfik, Ashleigh P. Scott, Catelyn Cashion, James Schwarer, Matthew J. Gleeson, Joanne L. Tan, Michael Ashby, John Coutsouvelis, Shevon Fernando, Louis Do, Bianca Cirone, Shu M. Wong, Sushrut S. Patil, Shafqat Inam, Bradley J. Gardiner, Shaun A. Fleming, Andrew P. Grigg, Andrew Spencer, David J. Gottlieb, C. Orla Morrissey, David J. Curtis
Adjusting Disease Risk Index for Regional Variations and Donor Selection
Makoto Iwasaki, Yachiyo Kuwatsuka, Hiromi Hayashi, Shinichi Kobayashi, Marie Ohbiki, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda, Masatsugu Tanaka, Tetsuya Nishida, Yuta Hasegawa, Toshiro Kawakita, Yuta Katayama, Tetsuya Eto, Yoshinobu Kanda, Fumihiko Ishimaru, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda
Brexucabtagene autoleucel in the Outpatient Setting, A Single Institution Experience
Grace Johnson Mercadante, Phavina Akhom, Nur Ali, Brittney Baer, Eden Biltibo, Bhagirathbhai Dholaria, Brian Hoeynck, Andrew Jallouk, Reena Jayani, Salyka Sengsayadeth, James Jerkins, Adetola Kassim, Nancy Long, David Morgan, Vivek Patel, Bipin Savani, Olalekan Oluwole, Shakthi Bhaskar
Poor graft function (PGF) following in vivo T cell–depleted allogeneic stem cell transplantation: the role of delayed immune reconstitution
Davide Murgia, Alessandra Algarotti, Chiara Pavoni, Benedetta Rambaldi, Giuliana Rizzuto, Maria Chiara Finazzi, Elena Oldani, Orietta Spinelli, Cristian Meli, Alessandro Rambaldi, Federico Lussana, Anna Grassi
Toward a Standardized Definition of Reduced-Dose Post-Transplant Cyclophosphamide in Allogeneic Hematopoietic Cell Transplantation
Nihar Desai, Jonas Mattsson
Frequently asked questions
How long does it take to publish?
3 days from submission to first decision; 29 days from submission to decision after review; 74 days from submission to acceptance; 5 days from acceptance to online publication.
Reformat to Transplantation And Cellular Therapy using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should identify the corresponding author’s name, address, phone number, fax number, and e-mail address, specify the manuscript category and word count, include prior peer review information for Fast Track submissions, and indicate willingness to pay extra costs for color photographs when applicable.
Reformat to Transplantation And Cellular Therapy using Livewrite PremiumWhat are the publication costs?
Open access APC is USD 4000 excluding taxes for all articles. Subscription publication has no open access publication fee.
Reformat to Transplantation And Cellular Therapy using Livewrite Premium